Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-056578
Filing Date
2025-06-05
Accepted
2025-06-05 06:00:15
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517204-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517204-1_4seq1.xml 4 3113
  Complete submission text file 0001104659-25-056578.txt   4622
Mailing Address 1223 FOXGLOVE LANE WEST CHESTER PA 19380
Business Address
Maccecchini Maria-Luisa (Reporting) CIK: 0001315018 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 251024952

Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)